Michaelson Jennifer — SEC insider filings

SEC reporting owner CIK 1838061. 50 insider filings on record with FilingPulse; latest filed 2026-11-06.

Transaction summary — filings shown

Covers all 50 filings on record, filed 2021-01-11 to 2026-11-06. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Cullinan Therapeutics, Inc. (CGEM)Chief Scientific Officer50—54 legs · 253,555 sh · $4,870,39551

Insider filings — Michaelson Jennifer

FiledFormIssuerReported transactionsSource
2026-11-064Cullinan Therapeutics, Inc. (CGEM)Option exercise (M): 3,805 @ $4.30 · Sale (S): 4,000 @ $12.36 · Option exercise (M): 3,805 (derivative) @ $0EDGAR
2026-09-104Cullinan Therapeutics, Inc. (CGEM)Option exercise (M): 4,000 @ $4.30 · Sale (S): 8,000 @ $21.57 · Option exercise (M): 4,000 (derivative) @ $0EDGAR
2026-08-144Cullinan Therapeutics, Inc. (CGEM)Option exercise (M): 30,000 @ $4.30 · Sale (S): 30,000 @ $20.26 · Option exercise (M): 30,000 (derivative) @ $0EDGAR
2026-07-074Cullinan Therapeutics, Inc. (CGEM)Option exercise (M): 4,000 @ $4.30 · Sale (S): 8,000 @ $17.82 · Option exercise (M): 4,000 (derivative) @ $0EDGAR
2026-05-064Cullinan Therapeutics, Inc. (CGEM)Option exercise (M): 4,000 @ $4.30 · Sale (S): 7,800 @ $14.60 · Sale (S): 200 @ $15.58 · Option exercise (M): 4,000 (derivative) @ $0EDGAR
2026-03-094Cullinan Therapeutics, Inc. (CGEM)Option exercise (M): 4,000 @ $4.30 · Sale (S): 8,000 @ $15.68 · Option exercise (M): 4,000 (derivative) @ $0EDGAR
2026-02-264Cullinan Therapeutics, Inc. (CGEM)Sale (S): 1,780 @ $14.14EDGAR
2026-02-254Cullinan Therapeutics, Inc. (CGEM)Sale (S): 1,752 @ $13.99 · Sale (S): 3,601 @ $14.47EDGAR
2026-02-234Cullinan Therapeutics, Inc. (CGEM)Sale (S): 3,742 @ $13.62 · Option exercise (M): 8,000 @ $4.30 · Sale (S): 8,000 @ $14.30 · Option exercise (M): 8,000 (derivative) @ $0EDGAR
2026-02-194Cullinan Therapeutics, Inc. (CGEM)Grant/award (A): 57,500 @ $0 · Grant/award (A): 115,000 (derivative) @ $0EDGAR
2026-02-134Cullinan Therapeutics, Inc. (CGEM)Sale (S): 416 @ $12.03EDGAR
2026-01-234Cullinan Therapeutics, Inc. (CGEM)Sale (S): 4,000 @ $12.30EDGAR
2025-12-224Cullinan Therapeutics, Inc. (CGEM)Sale (S): 1,345 @ $10.01EDGAR
2025-12-194Cullinan Therapeutics, Inc. (CGEM)Sale (S): 2,898 @ $9.67EDGAR
2025-12-164Cullinan Therapeutics, Inc. (CGEM)Sale (S): 2,148 @ $12.38 · Sale (S): 995 @ $11.90EDGAR
2025-11-254Cullinan Therapeutics, Inc. (CGEM)Sale (S): 4,000 @ $12.30EDGAR
2025-02-274Cullinan Therapeutics, Inc. (CGEM)Sale (S): 3,756 @ $8.53EDGAR
2025-02-214Cullinan Therapeutics, Inc. (CGEM)Grant/award (A): 50,000 @ $0 · Grant/award (A): 100,000 (derivative) @ $0EDGAR
2025-01-074Cullinan Therapeutics, Inc. (CGEM)Sale (S): 4,000 @ $12.51EDGAR
2024-12-204Cullinan Therapeutics, Inc. (CGEM)Sale (S): 4,693 @ $11.41EDGAR
2024-12-164Cullinan Therapeutics, Inc. (CGEM)Sale (S): 3,489 @ $12.52EDGAR
2024-11-074Cullinan Therapeutics, Inc. (CGEM)Sale (S): 8,000 @ $15.64EDGAR
2024-09-094Cullinan Therapeutics, Inc. (CGEM)Sale (S): 8,000 @ $18.09EDGAR
2024-07-094Cullinan Therapeutics, Inc. (CGEM)Sale (S): 8,000 @ $16.33EDGAR
2024-07-024Cullinan Therapeutics, Inc. (CGEM)Grant/award (A): 2,360 @ $9EDGAR
2024-05-084Cullinan Therapeutics, Inc. (CGEM)Option exercise (M): 50,000 @ $4.30 · Sale (S): 37,723 @ $27.82 · Sale (S): 20,277 @ $28.54 · Option exercise (M): 5,606 @ $4.30 · Sale (S): 5,606 @ $30.06 · Option exercise (M): 50,000 (derivative) @ $0 · +1 moreEDGAR
2024-02-234Cullinan Oncology, Inc. (CGEM)Grant/award (A): 50,000 @ $0 · Grant/award (A): 100,000 (derivative) @ $0EDGAR
2023-12-224Cullinan Oncology, Inc. (CGEM)Sale (S): 1,145 @ $8.50EDGAR
2023-12-204Cullinan Oncology, Inc. (CGEM)Sale (S): 238 @ $8.22EDGAR
2023-12-134Cullinan Oncology, Inc. (CGEM)Sale (S): 1,068 @ $7.81EDGAR
2023-06-214Cullinan Oncology, Inc. (CGEM)Sale (S): 238 @ $12.94EDGAR
2023-06-144Cullinan Oncology, Inc. (CGEM)Sale (S): 176 @ $13.11EDGAR
2023-06-084Cullinan Oncology, Inc. (CGEM)Option exercise (M): 11,900 @ $4.30 · Sale (S): 11,900 @ $12.31 · Option exercise (M): 100 @ $4.30 · Sale (S): 100 @ $12.40 · Option exercise (M): 11,900 (derivative) @ $0 · Option exercise (M): 100 (derivative) @ $0EDGAR
2023-05-194Cullinan Oncology, Inc. (CGEM)Sale (S): 239 @ $8.76EDGAR
2023-05-164Cullinan Oncology, Inc. (CGEM)Sale (S): 193 @ $8.78EDGAR
2023-04-204Cullinan Oncology, Inc. (CGEM)Sale (S): 238 @ $10.71EDGAR
2023-04-144Cullinan Oncology, Inc. (CGEM)Sale (S): 176 @ $10.22EDGAR
2023-03-274Cullinan Oncology, Inc. (CGEM)Sale (S): 238 @ $11.32EDGAR
2023-02-214Cullinan Oncology, Inc. (CGEM)Grant/award (A): 38,500 @ $0 · Grant/award (A): 77,000 (derivative) @ $0EDGAR
2022-11-294Cullinan Oncology, Inc. (CGEM)Option exercise (M): 4,000 @ $4.30 · Sale (S): 4,000 @ $13.30 · Option exercise (M): 4,000 (derivative) @ $0EDGAR
2022-09-294Cullinan Oncology, Inc. (CGEM)Option exercise (M): 4,000 @ $4.30 · Sale (S): 4,000 @ $12.40 · Option exercise (M): 4,000 (derivative) @ $0EDGAR
2022-08-094Cullinan Oncology, Inc. (CGEM)Option exercise (M): 1,385 @ $4.30 · Sale (S): 1,385 @ $15.01 · Option exercise (M): 1,385 (derivative) @ $0EDGAR
2022-07-264Cullinan Oncology, Inc. (CGEM)Option exercise (M): 8,000 @ $4.30 · Sale (S): 8,000 @ $14.51 · Option exercise (M): 8,000 (derivative) @ $0EDGAR
2022-07-054Cullinan Oncology, Inc. (CGEM)Grant/award (A): 1,620 @ $10.90EDGAR
2022-02-154Cullinan Oncology, Inc. (CGEM)Grant/award (A): 28,500 @ $0 · Grant/award (A): 57,000 (derivative) @ $0EDGAR
2021-10-204Cullinan Oncology, Inc. (CGEM)Option exercise (M): 4,000 @ $4.30 · Sale (S): 3,396 @ $21.10 · Sale (S): 204 @ $22.40 · Sale (S): 400 @ $23.61 · Option exercise (M): 4,000 (derivative) @ $0EDGAR
2021-09-214Cullinan Oncology, Inc. (CGEM)Option exercise (M): 4,000 @ $4.30 · Sale (S): 3,200 @ $24.34 · Sale (S): 800 @ $25.20 · Option exercise (M): 4,000 (derivative) @ $0EDGAR
2021-08-264/ACullinan Oncology, Inc. (CGEM)Option exercise (M): 4,000 @ $4.30 · Sale (S): 2,863 @ $27.50 · Sale (S): 1,137 @ $28.07 · Option exercise (M): 4,000 (derivative) @ $0EDGAR
2021-08-244Cullinan Oncology, Inc. (CGEM)Option exercise (M): 4,000 @ $4.30 · Sale (S): 2,863 @ $27.50 · Sale (S): 1,137 @ $28.07 · Option exercise (M): 4,000 (derivative) @ $0EDGAR
2021-01-114Cullinan Management, Inc. (CGEM)Grant/award (A): 79,999 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2021-01-06 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1838061 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs